cabergoline has been researched along with Carcinogenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Cao, L; Guo, YH; Huang, JY; Liu, YT; Rui, WW; Shang, HB; Su, B; Tang, H; Wang, Y; Wei, YX; Wu, ZB; Wu, ZR; Yan, L; Yang, G; Yao, H; Zhang, XB; Zhang, Y; Zhao, WG | 1 |
1 other study(ies) available for cabergoline and Carcinogenesis
Article | Year |
---|---|
Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cabergoline; Carcinogenesis; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Female; HEK293 Cells; Heterografts; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Phosphoproteins; Phosphorylation; Pituitary Neoplasms; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Long Noncoding; Up-Regulation | 2018 |